Application of SARS-CoV-2 NGS

This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 101003589.

•

•

•

•

83 overlappende amplicons 500bp75 bp overlap

•

•

•

•

Lineage

A

A.2

A.5

B

B.1

B.1.1

B.1.10

B.1.11

B.1.13

B.1.22

B.1.5

B.1.5.2

B.1.7

B.1.8

B.1.9

B.2

B.2.1

B.2.3

B.2.5

B.3

B.45.0E-5

•

•

•

•

Ongoing..

• Monitoring of relevant mutations

• Longitudinal monitoring patients

• Househld studies

• Animal studies

Consortium partners